Adjuvant paclitaxel (P)/carboplatin (C) in stages I, II non-small cell lung cancer (NSCLC): Comparison of two schedules in phase II trials by the Minnie Pearl Cancer Research Network

Autor:	James D. Bearden, C. E. McKay, D. A. Yardley, Sharlene Litchy, Gerry Ann Houston, David R. Spigel, H. A. Burris, John D. Hainsworth, Daniel C. Scullin, F. A. Greco
Rok vydání:	2005
Předmět:	Oncology Cancer Research medicine.medical_specialty business.industry medicine.medical_treatment non-small cell lung cancer (NSCLC) medicine.disease Carboplatin Stage ib chemistry.chemical_compound chemistry Paclitaxel Internal medicine medicine Adjuvant therapy Cancer research business Adjuvant
Zdroj:	Journal of Clinical Oncology. 23:7123-7123
ISSN:	1527-7755 0732-183X
Popis:	7123 Background: Adjuvant therapy with P (200mg/m2)/C (AUC=6) every 3 weeks for 4 cycles is associated with a 13% increase of survival in stage IB NSCLC patients (pts) (Late/breaking abstracts from...
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::04f29f498827ad9aab8af56f8526ea8e https://doi.org/10.1200/jco.2005.23.16_suppl.7123 Zobrazit plný text záznamu